
Breakthrough Shot Sees Rising HIV Prevention Demand, but Insurance Barriers Limit Access in the US
Uptake Grows for Revolutionary HIV Prevention Injection A new HIV prevention injection developed by Gilead Sciences is gaining traction across the United States, signaling a potential shift in how pre-exposure prophylaxis (PrEP) is delivered. The drug, marketed as Yeztugo, is…









